Literature DB >> 7369811

Femoral triangle sepsis in dialysis patients: frequency, management, and outcome.

A P Morgan, D C Knight, N L Tilney, J M Lazarus.   

Abstract

Prosthetic devices for dialysis access sometimes have to be implanted in the groin. Infections are frequent there, and when they occur their management is influenced by the patients' need for continued dialysis, and often, by the presence of concomitant diseases. We report implantation of 161 dialysis access devices of various types, all utilizing the femoral vessels. Twenty-seven femoral triangle injections eventually occurred. Both the approach to their treatment and outcome were influenced by mode of presentation, localized infection being most favorable, and fever without localized signs least. The compromise surgical procedures made necessary by the patients' precarious medical status were successful in most instances but overall mortality was 18%, and the amputation rate 22%.

Entities:  

Mesh:

Year:  1980        PMID: 7369811      PMCID: PMC1344568          DOI: 10.1097/00000658-198004000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  Management of sepsis complicating arterial reconstructive surgery.

Authors:  R S SHAW; A E BAUE
Journal:  Surgery       Date:  1963-01       Impact factor: 3.982

2.  Cannulation of blood vessels for prolonged hemodialysis.

Authors:  W QUINTON; D DILLARD; B H SCRIBNER
Journal:  Trans Am Soc Artif Intern Organs       Date:  1960 Apr 10-11

3.  Effects of infection and exposure on synthetic arterial prostheses.

Authors:  R J SCHRAMEL; O CREECH
Journal:  AMA Arch Surg       Date:  1959-02

4.  Cause of death in acute renal failure.

Authors:  J F MAHER; G E SCHREINER
Journal:  Arch Intern Med       Date:  1962-10

5.  Infection in arterial reconstruction with synthetic grafts.

Authors:  D E Szilagyi; R F Smith; J P Elliott; M P Vrandecic
Journal:  Ann Surg       Date:  1972-09       Impact factor: 12.969

Review 6.  Renal failure and infection.

Authors:  J Z Montgomerie; G M Kalmanson; L B Guze
Journal:  Medicine (Baltimore)       Date:  1968-01       Impact factor: 1.889

7.  A large-vessel applique A-V shunt for hemodialysis.

Authors:  G I Thomas
Journal:  Trans Am Soc Artif Intern Organs       Date:  1969

8.  Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.

Authors:  M J Brescia; J E Cimino; K Appel; B J Hurwich
Journal:  N Engl J Med       Date:  1966-11-17       Impact factor: 91.245

9.  Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function.

Authors:  J M Malone; W S Moore; G Campagna; B Bean
Journal:  Surgery       Date:  1975-08       Impact factor: 3.982

10.  Septicemia in patients on chronic hemodialysis.

Authors:  J F Dobkin; M H Miller; N H Steigbigel
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

  10 in total
  5 in total

1.  Percutaneous transluminal angioplasty for dysfunctional femoral hemodialysis graft.

Authors:  Eunsun Oh; Yong Jae Kim; Dong Erk Goo; Seungboo Yang; Seongsook Hong
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

2.  Vascular access surgery for hemodialysis.

Authors:  D D Nghiem
Journal:  Ann Surg       Date:  1982-12       Impact factor: 12.969

3.  Percutaneous intervention in axillary loop-configured arteriovenous grafts for chronic hemodialysis patients.

Authors:  Beom Jin Park; Hyoung Rae Kim; Hwan Hoon Chung; Deuk Jae Sung; Sang Joon Park; Ho Sung Son; Sang Kyung Jo; Yun Hwan Kim; Sung Bum Cho
Journal:  Korean J Radiol       Date:  2010-02-22       Impact factor: 3.500

4.  Long Term Outcomes of Arteriovenous Grafts for Hemodialysis in Lower Extremities.

Authors:  Seok Han; Dan Song; Sangchul Yun
Journal:  Vasc Specialist Int       Date:  2016-12-31

5.  Midterm experience of ipsilateral axillary-axillary arteriovenous loop graft as tertiary access for haemodialysis.

Authors:  J P Hunter; M L Nicholson
Journal:  J Transplant       Date:  2014-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.